复发性恶性心周溢血的管理:心周周周周的窗口
Antonio Mazzella1, Giovanni Caffarena1, Claudia Bardoni1
1Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Journal of clinical medicine
|January 10, 2026
概括
心周周围膜窗口 (PPW) 是一种安全有效的手术选择,用于在预后良好的患者中管理恶性心周周周围膜溢出 (MPE). 对于那些前景不太好的人来说,建议进行心周排水.
科学领域:
- 在瘤学瘤学.
- 心胸外科手术 心胸外科手术
- 抚慰性护理是一种缓解性护理.
背景情况:
- 恶性心周溢出 (MPE) 是固体瘤的罕见但具有挑战性的并发症.
- 管理MPE往往需要有效和安全的治疗策略.
研究的目的:
- 评估心周-腹膜窗口 (PPW) 作为MPE的最终治疗方法的疗效和长期结果.
- 将PPW与MPE的其他管理策略进行比较.
主要方法:
- 在2010年至2023年期间接受PPW的44名患者的回顾性和前性分析.
- 收集的数据包括手术,并发症,死亡率和复发率.
- 相关的手术如视频胸腔镜和皮肤间排水也得到了注意.
主要成果:
- 30天的死亡率为9%.
- 对PPW的成功率,定义为没有需要进一步干预的复发,为95.5%.
- 8名患者出现心周溢血的复发,只有2名患者需要进一步干预.
结论:
- 周心周窗 (PPW) 是对MPE的安全有效的最终治疗方法,用于短期预后有利的患者.
- 穿皮心周排水是对预后不太有利的患者更合适的治疗方法.
相关概念视频
Pericarditis III: Medical Management
298
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
298
Pericarditis IV: Nursing Management
309
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
309
Pleural Effusion II: Symptoms and Management
628
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
628
Pericarditis I: Introduction
319
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
319
Pericarditis II: Clinical Features and Diagnostic Tests
274
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
274
Mitral Regurgitation III: Medical Management
264
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
264


